We’re working for a world where no one dies from skin cancer

At Skin Analytics we’re committed to helping more people survive skin cancer by using AI to enable innovative skin cancer pathways that deliver better patient outcomes that are sustainable for health systems globally.

With our AI as a Medical Device (AIaMD), DERM, we are striving to dramatically improve access to dermatologist quality skin cancer assessments, while reducing the financial burden of skin cancer on health systems around the world.

Meet our management team

Neil Daly


Neil started Skin Analytics in 2012, having worked extensively in mobile innovation and strategy consulting for a number of years. He holds a BSc in Physics from the University of Western Australia and an Executive MBA from London Business School.

Rachael Dovey

Business Development Director

Rachael is an experienced commercial partnerships manager, with over a decade of experience working with the NHS. Rachael is passionate about redesigning services and pathways in order to deliver better patient care, while being sustainable for the NHS.

Dr Jack Greenhalgh

AI Director

Jack joined Skin Analytics having worked in computer vision and machine learning in both industry and academia for many years. He holds an MEng in Computer Systems Engineering from the University of Sussex and a Ph.D. in Computer Science from the University of Bristol.

David Puttergill

Operations Director

David has 12 years of experience in Accounting, Finance and Operations in professional services, start-ups and FCA regulated lending. David is a Chartered Accountant (ICAEW) and has a BA in Geography from Oxford.

Dr Dan Mullarkey

Medical Director

Dan is a practicing GP who has experience working within the AI & Digital Health settings. He sees the adoption of digital health technologies as key in helping healthcare services to evolve to offering support & efficiency improvements and optimise patient experience. Dan holds degrees in Medicine (BMBS) and Biomedical Sciences (BMedSci) from the University of Nottingham.

Jim Holmes

Technology Director

Jim has been working in technology for the last 20 years and is an experienced software engineer and technical architect. He joined the Skin Analytics team after a 10 year position as CTO of a digital agency in London. Jim has experience of building and scaling technology focused start-up businesses as well as previous experience in medical technology. Jim holds a BSc in Information Systems.

James Hamlyn

Quality and Regulatory Director

James has over 12 years experience in medical device regulatory and quality affairs with large and small medtech companies across multiple geographies, including UK, USA and Japan. He has a keen interest in software as a medical device and is excited about the future of AI in medical applications.

Dr Helen Marsden

Clinical Research Director

Helen has 17 years of clinical research experience in both corporate and academic settings delivering clinical trials and data generation. She has authored seven peer-reviewed journals. Helen has a PhD in medical microbiology from Leeds University.

Snigdha Jain

Product Director

Snigdha heads the team that builds and designs our products. Previously, Snigdha was a Product Leader at Babylon. She is an engineer by education who later pursued an MBA and a masters in Machine Learning from the US. In her 17+ years of professional experience, Snigdha has led product development in multiple countries and across industries and companies at varying stages of growth. She is a people oriented leader specialising in building high performing teams and passionate about growing products from 0 to 1 and beyond

Our board

Dominic Dodd

Chair, Non Executive Director, Advisor

Dominic Dodd is chair of UCLPartners the health innovation partnership, and of UCL Health Alliance, the healthcare collaborative based in north central London. He is vice chair of health and care think tank The King’s Fund and a trustee of UK Biobank, the biomedical research resource.

Previously he chaired two NHS trusts: from 2010–2021 he was chair of The Royal Free London NHS Foundation Trust, one of the UK’s largest acute trusts; and from 2019-2023 he was chair of The Royal National Orthopaedic Hospital NHS Trust which specialises in tertiary neuro-muscular-skeletal services, education and research.

Before his time in health care, Dominic was a managing partner of Marakon Associates, a strategy consulting firm.

Juan Pane Arregui

Entrepreneur and Business Angel

Juan spent 9 years working in software development at companies in Argentina and Spain and developed an anti virus in his free time. In 1995, he started Media Net Software and sold the company after 20 years while it was employing 200+ engineers in Spain, Mexico and the USA. From 1998 to 2004 Juan managed the digitizing projects for Diario El País and Diario El Mundo through a corporate venture we created ad-hoc, where they hired a team of 70+ professionals.
He is Current owner of Evoluciona, a digital interactive agency. He was the CEO from 2005 to 2013 and saw the company grow to work with blue chip companies such as Microsoft, BBVA, Acciona, RTVE, FOX or El Corte Inglés.
In 2005 he co-founded BuyVIP with two other partners. This e-commerce site grew to 100+ employees in five years and was operating in Germany, Italy, Spain, Portugal, Austria, Poland and The Netherlands. BuyVIP was sold to Amazon in 2010. In 2009 Juan co-founded Tech on Rails, an engineering services company specialized in high-speed trains and aeronautics.
Juan is an investor, advisor and/or board member at several companies and is always open to new opportunities where business strategy, processes or technology can be applied to move companies to the next stage.

Michael Buchen

Chairman of Polar Light Ventures Ltd and Investor

Michael is the Chairman and Founder of Polar Light Ventures Ltd., an investment firm based in Switzerland which is focusing on early stage ventures.
Previously he was the Managing Director of Dhabi Holdings PJSC, the investment company of senior members of the ruling family of Abu Dhabi. Michael Buchen joined Dhabi Holdings from Mubadala Development Company PJSC where he worked in the Special Situations Team. Before Mubadala, he worked for Roland Berger Strategy Consultants in Europe, China and the Middle East. Michael currently serves or previously served on the Board of directors and Advisory Boards of a number of companies in the Venture Capital, Tech, Financial Services, Food & Beverage, Energy and Telecom sector.
He holds a Master of Science in Business Management from the University of Muenster in Germany.

Hussein Kanji

Partner at Hoxton Ventures

He currently represents Hoxton on the boards of Biotx, Fy!, Giraffe360, Kbox Global, Raptor Supplies, Skin Analytics, SOC.OS, TourRadar, XYZ Reality and Yieldify, and serves as a board observer on Behavox, Darktrace, Finesse, Karakuri, Loveshark, Panakeia and Vidya Health. He previously served on the boards of Babylon Health, bd4travel (acquired by Dnata), Campanja (acquired by 24/7 Media) and Deliveroo.
Hussein also serves on the board of Tech Nation. He also sits on the advisory board of GTO Partners, a tech mid-market buyout firm, and Landscape, a venture capital review site. While forming Hoxton, he helped Eros STX Global develop ErosNow, an online streaming video platform for Bollywood.
Prior to Hoxton, Hussein was an associate with Accel Partners. He joined Accel from Microsoft Corporation. Earlier in his career, he worked with three startups, Safe-View (acquired by L-3), Radiance Technologies (acquired by Comcast) and Studio Verso (acquired by KPMG).
Hussein holds an MBA from London Business School and did his undergraduate studies in Symbolic Systems at Stanford University. 

Clinical Advisory Commitee

Professor Scott Kitchnener​

Primary Care Medical Service Director​

Scott is a qualified specialist in medical leadership and management (FRACMA), a graduate of the AICD, a specialist public health physician (FAFPHM), while remaining a clinician with specialist standing as a general practitioner in rural practice. He has experience in health and education corporate governance and leadership in the private sector, public sector, higher education sector, international and Australian biotech sectors and in the military. His on-going research and experience have been in addressing health issues of developing nations, rural health and workforce, and particularly preventive approaches to public health challenges.

Dr Niall Wilson

Consultant Dermatologist

Niall qualified in Medicine from the University of Liverpool in 1991. He has been an NHS Consultant Dermatologist since 2000. He has special interests in skin cancer, hyperhidrosis and skin disorders in immunosuppressed patients. He has also been involved with postgraduate education for many years and is currently vice chair of the Specialist Advisory Committee for Dermatology, which oversees Dermatology training in the UK.

Dr Lucy Thomas​

Consultant Dermatologist​

Dr Lucy Thomas MPharm MBChB MRCP UK (Dermatology) qualified from the University of Birmingham with a first-class honours medical degree. She works as an NHS Consultant Dermatologist at Chelsea & Westminster Hospital where she carries out general and complex medical dermatology clinics as well as skin surgery.
Lucy has a passion for innovation and digital technologies and has attended the Exponential Medicine course run by Singularity University in San Diego. She has helped to establish a successful teledermatology service for urgent two week wait referrals at Chelsea & Westminster hospital which has now managed over 3000 patients, the results of which she has presented nationally on multiple occasions.

Professor Chris Hyde​

Health Economics​

Chris is a professor of Public Health and Clinical Epidemiology at Exeter University. He is a School lead for research on test evaluation including systematic reviews, economic models and primary research. He leads the Exeter Test Group and is the diagnostics theme lead for PenCLAHRC. He is part of the Peninsula Technology Assessment Group (PenTAG). He directed the team delivering health technology assessments for national policy-making bodies, particularly NICE, from 2009 until 2015 and continues to support it by being the lead on HTAs of tests and through membership of its steering group. He is a long standing member of NICE’s Diagnositc Advisory Committee and recently joined the National Screening Committee.

Justin M Ko, MD, MBA​

Clinical Professor, Dermatology Stanford University​

Dr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department’s efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including co-chairing the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care’s Ambulatory clinics, and as a Service Medical Director.
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artifical intelligence to increase the breadth of populations that can be reached. He chairs the American Academy of Dermatology’s Task Force Committee on Augmented Intelligence.

Subscribe to our news updates

We won't spam
you, we promise.